Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,464 total articles

Thunder Bridge Capital Partners V, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 5, 2026

Thunder Bridge Capital Partners V, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 5, 2026

Thunder Bridge Capital Partners V, Ltd., a blank check company listed on Nasdaq, announced that holders of its units sold in the IPO can elect to separate and trade Class A ordinary shares and warrants individually starting October 5, 2026. The shares and warrants will trade under symbols TBCV and TBCVW respectively, while unseparated units will co…

Hub Group Announces Changes to Board of Directors

Hub Group Announces Changes to Board of Directors

Hub Group, Inc. announced major changes to its Board of Directors following a consent action by controlling shareholders, appointing four new directors and removing three without cause. The company also adopted amended bylaws and is actively appealing Nasdaq's decision to initiate delisting due to delayed financial filings. The changes aim to reinf…

Rogers Brings Backstreet Boys to Canada

Rogers Brings Backstreet Boys to Canada

Rogers Communications partners with Live Nation Canada to present the Backstreet Boys' only 2027 North American stadium shows, offering exclusive presale and premium experiences to Rogers customers. The concert residency celebrates the seminal 'Millennium' album and strengthens Rogers' entertainment portfolio, enhancing customer loyalty and engagem…

Invitation to Nova’s Investor Update Webinar

Invitation to Nova’s Investor Update Webinar

Nova Minerals Corp invites investors to a webinar to discuss recent advancements at its Estelle Gold and Critical Minerals Project in Alaska and new capabilities in antimony processing and refining at Port MacKenzie. The company's efforts are supported by a $43.4 million award from the U.S. Department of War to establish a secure domestic antimony …

The Ensign Group Adds New Operations in Colorado

The Ensign Group Adds New Operations in Colorado

The Ensign Group, a US-based skilled nursing and senior living services provider, announced acquisitions of several skilled nursing and healthcare facilities in Colorado, Florida, and Washington. These transactions increase Ensign's portfolio to 418 healthcare operations in 18 states and include both operational and real estate acquisitions, streng…

The Ensign Group Adds Operations in Washington

The Ensign Group Adds Operations in Washington

The Ensign Group announced multiple acquisitions of skilled nursing and senior living facilities in Washington, Florida, and Colorado. The new facilities add a substantial number of nursing beds and senior living units, expand Ensign's footprint to 418 healthcare operations across 18 states, and include real estate acquisitions through its captive …

The Ensign Group Announces Expansion Into Florida

The Ensign Group Announces Expansion Into Florida

The Ensign Group, Inc. announces its expansion into the Florida healthcare market through the acquisition of multiple skilled nursing and rehabilitation facilities, totaling over 700 beds and independent living units. Additionally, Ensign expanded its operations in Colorado and Washington by acquiring several healthcare facilities. These strategic …

Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)

Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)

Ultragenyx Pharmaceutical has announced that the European Medicines Agency has validated its Marketing Authorization Application for rebisufligene etisparvovec, an investigational gene therapy for treating Mucopolysaccharidosis type IIIA (Sanfilippo syndrome Type A). Validation allows EMA to begin formal scientific review, marking a significant reg…

New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program

New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program

Cullinan Therapeutics announced the initiation of a New Drug Application (NDA) submission to the FDA for zipalertinib combined with platinum-based chemotherapy to treat first-line EGFR exon 20 insertion mutation non-small cell lung cancer (NSCLC). The submission is under the FDA's Real-Time Oncology Review program to expedite review, with completio…

Phillips Edison & Company Reaffirms Full Year 2026 Earnings Guidance; Increases Full Year 2026 Gross Acquisitions Guidance; Provides Investment Update

Phillips Edison & Company Reaffirms Full Year 2026 Earnings Guidance; Increases Full Year 2026 Gross Acquisitions Guidance; Provides Investment Update

Phillips Edison & Company, a leading owner and operator of grocery-anchored shopping centers, updated its 2026 guidance by increasing full year gross acquisitions and disposition expectations. The company reaffirmed its earnings guidance, anticipating over 6% year-over-year growth in Core FFO per share, driven by an expanded joint venture partnersh…

JAKKS Pacific, Inc. Announces Third Quarter 2026 Earnings Call

JAKKS Pacific, Inc. Announces Third Quarter 2026 Earnings Call

JAKKS Pacific, a leading toy designer and manufacturer, announced it will release its third quarter 2026 financial results after market close on October 22, 2026, followed by an earnings call to discuss performance and future outlook. The company operates popular proprietary and licensed toy brands and maintains an active media presence.

Phillips Edison & Company Announces $377.5 Million Expansion of Joint Venture with Northwestern Mutual

Phillips Edison & Company Announces $377.5 Million Expansion of Joint Venture with Northwestern Mutual

Phillips Edison & Company has announced a $377.5 million expansion of its joint venture partnership with Northwestern Mutual, extending their Grocery Retail Partners I LLC deal to 2036. The expansion involves acquiring 13 high-quality grocery-anchored shopping centers across eight states. Phillips Edison will retain a 14% interest, continue managem…

ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit

ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit

ChronoScale Holdings Corporation announced expanded AI infrastructure agreements, boosting contracted annualized revenue run rate to $1 billion by Q3 2027. The company also completed the sale of its Ekso Bionics business unit, enabling a sharper focus on accelerated computing platforms optimized for AI workloads. These strategic moves highlight inc…